Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 357.6 INR -1.25% Market Closed
Market Cap: 243.2B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Wall Street
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 1 284.59 INR with a low forecast of 696.9 INR and a high forecast of 1 758.75 INR.

Lowest
Price Target
696.9 INR
49% Downside
Average
Price Target
1 284.59 INR
5% Downside
Highest
Price Target
1 758.75 INR
30% Upside
Natco Pharma Ltd Competitors:
Price Targets
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
20% Upside
DPHARMA
Duopharma Biotech Bhd
20% Upside
605116
Aurisco Pharmaceutical Co Ltd
49% Upside
688166
BrightGene Bio-Medical Technology Co Ltd
49% Upside
MEDCL
Medincell SA
28% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
47% Upside
2096
Simcere Pharmaceutical Group Ltd
36% Upside
688185
CanSino Biologics Inc
1% Upside

Revenue
Forecast

Revenue Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -2%.

18%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 28%. The projected CAGR for the next 3 years is -22%.

28%
Past Growth
-22%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 31%. The projected CAGR for the next 3 years is -16%.

31%
Past Growth
-16%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NATCOPHARM's stock price target?
Price Target
1 284.59 INR

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 1 284.59 INR with a low forecast of 696.9 INR and a high forecast of 1 758.75 INR.

What is Natco Pharma Ltd's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -2%.

What is Natco Pharma Ltd's Operating Income forecast?
Projected CAGR
-22%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 28%. The projected CAGR for the next 3 years is -22%.

What is Natco Pharma Ltd's Net Income forecast?
Projected CAGR
-16%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 31%. The projected CAGR for the next 3 years is -16%.

Back to Top